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The conserved protein Rap1 functions at telomeres
in fungi, protozoa, and vertebrates. Like yeast
Rap1, human Rap1 has been implicated in telomere
length regulation and repression of nonhomologous
end-joining (NHEJ) at telomeres. However, mouse
telomeres lacking Rap1 do not succumb to NHEJ.
To determine the functions of human Rap1,
we generated several transcription activator-like
effector nuclease (TALEN)-mediated human cell lines
lacking Rap1. Loss of Rap1 did not affect the other
components of shelterin, the modification of telo-
meric histones, the subnuclear position of telomeres,
or the 30 telomeric overhang. Telomeres lacking Rap1
did not show a DNA damage response, NHEJ, or
consistent changes in their length, indicating that
Rap1 does not have an important function in protec-
tion or length regulation of human telomeres. As hu-
man Rap1, like its mouse and unicellular orthologs,
affects gene expression, we propose that the con-
servation of Rap1 reflects its role in transcriptional
regulation rather than a function at telomeres.
INTRODUCTION
Rap1 is a component of shelterin, the protein complex that func-
tions to protect telomeres, recruits telomerase, and regulates
telomere length (reviewed in Palm and de Lange, 2008). Human
shelterin contains two double-stranded (ds) telomeric DNA bind-
ing proteins, TRF1 and TRF2, which both interact with TIN2. TIN2
in turn binds heterodimers of TPP1 and the POT1 single-
stranded (ss) telomeric DNA binding factor. Mammalian Rap1 re-
lies on TRF2 to localize to telomeres (Li et al., 2000). Similarly, the
Rap1 orthologs of fission yeast and trypanosomes use a TRF1/2-
like protein to accumulate at telomeres (Kanoh and Ishikawa,
2001; Yang et al., 2009). In contrast, budding yeast Rap1 binds
telomeric DNA directly (Konig et al., 1996).
Rap1 was discovered as a Saccharomyces cerevisiae tran-
scriptional regulator (repressor/activator protein) (Shore and
Nasmyth, 1987). All Rap1 proteins have an N-terminal BRCTCell Remotif, a C-terminal protein interaction domain, and one or two
central Myb domains (Konig et al., 1996; Liu and Lustig, 1996;
Hardy et al., 1992a; Wotton and Shore, 1997; Yang et al.,
2009; Kanoh and Ishikawa, 2001; Li et al., 2000). Budding yeast
Rap1 binds to promoter and silencer elements and interacts with
the silencing proteins Sir3p and Sir4p (Hardy et al., 1992a,
1992b; Shore, 1994; Lickwar et al., 2012; Cockell et al., 1995).
Although mammalian Rap1 does not interact with sirtuins, it
localizes to chromosome-internal sites and controls gene
expression, affecting metabolism and body weight control
(Yeung et al., 2013; Martı´nez et al., 2013; Yang et al., 2011).
Rap1 also regulates gene transcription in fission yeast and in
the distantly related trypanosomes (Kanoh and Ishikawa, 2001;
Yang et al., 2009).
It is unclear which telomeric functions of Rap1 are conserved
between yeast and mammals. Rap1 controls telomere length in
yeast, acting to inhibit inappropriate telomere elongation (Lustig
et al., 1990; Conrad et al., 1990; Sussel and Shore, 1991; Kyrion
et al., 1992; Kanoh and Ishikawa, 2001). This control of telomere
length is largely mediated by the Rap1-interacting factors Rif1
and Rif2 (Hardy et al., 1992a; Wotton and Shore, 1997; Levy
and Blackburn, 2004; Teixeira et al., 2004). In support of a role
in telomere length control, small hairpin RNAs (shRNAs) to hu-
man Rap1 induce telomere lengthening (O’Connor et al., 2004),
as do overexpression of several Rap1 truncation mutants (Li
and de Lange, 2003). However, Rap1 knockout mice show no
change in telomere length, even after three generations (Sfeir
et al., 2010). Additionally, mammalian Rif1 is not localized at telo-
meres (Silverman et al., 2004; Xu and Blackburn, 2004), and
there is no mammalian ortholog of Rif2.
It is also unclear whether the role of Rap1 in protection of telo-
meres from nonhomologous end-joining (NHEJ), which has been
demonstrated in yeast (Pardo and Marcand, 2005; Miller et al.,
2005), is conserved in mammals. In vitro, human Rap1 can block
NHEJ when it binds to TRF2 loaded on an end-joining substrate
(Bae andBaumann, 2007), and aRap1-fusion protein can reduce
telomere fusions when it is tethered to telomeres that are
depleted of TRF2 (Sarthy et al., 2009). On the other hand, mouse
cells lacking Rap1 show no telomere fusions and Rap1-deficient
mice are alive and fertile (Sfeir et al., 2010; Martinez et al., 2010).
The only telomere deprotection phenotype in Rap1-deficient
mouse cells is a propensity for telomere-telomere recombination
when Ku70/80 are also absent (Sfeir et al., 2010).ports 9, 1273–1280, November 20, 2014 ª2014 The Authors 1273
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To determine the function(s) of human Rap1, we used tran-
scription activator-like effector nucleases (TALENs) to knock
out the TERF2IP gene. Analysis of several independent Rap1-
deficient cell lines demonstrated that human Rap1 was not
required for telomere protection, telomere length regulation,
and other aspects of telomere function. In contrast, we docu-
ment a change in the transcription of several genes upon loss
of Rap1, suggesting that its transcriptional function is primarily
responsible for the high degree of Rap1 conservation from uni-
cellular organisms to mammals.
RESULTS
Efficient TALEN-Mediated Knockout of Human Rap1
The human Rap1-encoding TERF2IP gene shares its promoter
region with the essential KARS (lysyl-tRNA synthetase) gene
located just upstream of exon 1 (Figure 1A). To avoid disrupting
the KARS gene, we employed TALENs to delete exon 2, a
targeting strategy analogous to the one used for mouse
TERF2IP (Sfeir et al., 2010) (Figures 1A, S1A, and S1B). Dele-
tion of exon 2 should result in an mRNA encoding a 226 aa
open reading frame (ORF) that ends prematurely in a stop
codon at the beginning of exon 3. As exon 3 encodes the
TRF2-binding domain, the truncated Rap1 protein is not ex-
pected to localize to telomeres. Taking advantage of the small
size of exon 2 (125 bp) and anticipated resection of TALEN-
induced double-strand breaks (DSBs) (Chen et al., 2011; Urnov
et al., 2010), a neomycin donor construct was designed con-
taining 50 and 30 arms homologous to the surrounding introns.
Homology-directed repair (HDR) using the donor construct
should result in deletion of exon 2 and insertion of the neomycin
cassette.
TERF2IP was targeted in two near-diploid cancer lines
(HCT116 colorectal carcinoma and HT1080 fibrosarcoma), a
subclone of the near-triploid cervical carcinoma HeLa cell line
(HeLa1.3; Takai et al., 2010), the diploid ARPE-19 retinal pigment
epithelial cell line, and primary BJ fibroblasts transformed with
SV40 large T antigen (SV40LT). With the exception of SV40LT
BJ, all cells expressed telomerase. For HCT116, HT1080, and
ARPE-19 cells, neomycin resistant clones were obtained,
analyzed by PCR, and then evaluated by Southern blotting to
verify the correct neomycin insertion (Figures 1B and 1C). For
HeLa1.3 and BJ, the blasticidin donor construct was used and
clones were analyzed by immunoblotting for Rap1. This analysis
identified clones that lacked the wild-type TERF2IP gene and ex-
pressed no detectable Rap1 protein (Figures 1B, 1C, and S1C).
We were unable to detect the polypeptides representing the re-Figure 1. TALEN-Mediated Inactivation of the Gene for Human Rap1
(A) Schematic of human Rap1, the TERF2IP locus, the targeting construct, and t
Arrows in bold: TALEN binding and cut sites.
(B) PCR genotyping of the TERF2IP gene and western blotting for Rap1 in the in
of Rap1.
(C) Southern blot of EcoRI (RI)- or BglII/EcoRV (RV)-digested genomic DNA from
(D) Telomeric ChIP of WT and targeted HT1080 clones. Duplicate dot-blots were
(E) Average percentage of telomeric DNA recovered in ChIPs with the indicated
(F) Schematic illustrating NHEJ and HDR after TALEN cutting.
(G) Table indicating number of Rap1 knockout clones acquired and the genetic a
See also Figure S1.
Cell Remaining ORF of the targeted TERF2IP gene (Figures S1D–S1F),
perhaps due to nonsense-mediated decay.
Unexpectedly, immunoblotting revealed the complete loss of
Rap1 in heterozygous clones with one neo insertion (Figures
1B and S1C). Telomeric chromatin immunoprecipitation (ChIP)
of two such clones (HT1080 c21 and HeLa1.3 c28) confirmed
that Rap1 was absent from telomeres (Figures 1D, 1E, S1G,
and S1H). Sequencing revealed small deletions close to the
TALEN site in these and other Rap1-deficient clones with only
one neo-containing TERF2IP gene (Figure S1B). Most mutations
had ablated Rap1 by deleting the exon 2 splice acceptor site or
had created a frameshift mutation, indicating that errors gener-
ated during NHEJ had inactivated the TERF2IP gene (Figure 1F).
As a result, the frequency of the TERF2IP knockouts (KOs) is
much higher than deduced from PCR genotyping. Taking the
deleterious repair events into account, the ablation of Rap1
occurred at 20%–65% efficiency in HCT116, HT1080, and
ARPE-19 cells (Figure 1G). The HCT116 cells showed the highest
KO frequency consistent with their propensity for HDR (reviewed
in Sedivy et al., 1999). The actual KO frequency is probably even
higher, as only clones with a neo cassette in the TERF2IP gene
were analyzed.
The high KO frequency allowed screening of HeLa1.3 and
SV40LT BJ clones by Rap1 immunoblotting. Sequencing of
Rap1-negative HeLa1.3 clones revealed that all three alleles in
this cell line contained inactivating mutations near the TALEN
cut site (Figure S1B). Prolonged culturing of clones in blasticidin
resulted in cell death, suggesting that the EF-1 alpha promoter
(pEF) blasticidin cassette did not confer long-term resistance.
The KO frequency was lower in SV40LT BJ fibroblasts with only
one blasticidin-resistant clone showing absence of Rap1 protein.
This clone was not analyzed because it perished in telomere
crisis, as did many of the Rap1-proficient SV40LT BJ clones.
Rap1-Deficient Cells Proliferate and Maintain Fully
Protected Telomeres
The Rap1-deficient cell lines proliferated normally (Figure 2A)
and lacked a significant level of telomere dysfunction-induced
foci (TIFs), a readout for telomere damage (Figures 2B and 2C),
indicating that removal of Rap1 from telomeres does not result
in a DNA damage response.
Cells lacking Rap1 also did not show a significant induction of
DSB repair at telomeres (Figures 2D and 2E). Metaphase
spreads of Rap1 KOs lacked chromosome end fusions, a
readout for telomeric NHEJ. Chromosome orientation (CO) fluo-
rescence in situ hybridization (FISH) to monitor HDR-mediated
telomere-sister chromatid exchanges (T-SCEs) establishedhe resulting knockout allele. F1, R1, and R2neo: PCR primers for genotyping.
dicated clones. +, WT allele; D, targeted allele; mut, mutation resulting in loss
targeted HT1080 clones. Probe shown in (A).
probed for telomeric or Alu repeats.
antibodies (two independent experiments). Error bars represent SEM.
lterations in TERF2IP.
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Figure 2. Telomere Protection in Rap1-Deficient Cells
(A) Growth curves of WT and Rap1 KO HT1080 clones.
(B) TIF assay on WT and KO HeLa1.3 clones. Green, telomeric FISH; red, immunofluorescence for 53BP1; blue, DNA (DAPI).
(C) Quantification of TIF assay (see B). Error bars represent SDs of three independent experiments (nR 100 nuclei per clone). p values from a two-tailed paired
t test combining WT and KO data sets. n.s., not significant.
(D) Metaphase chromosomes from the indicated WT and Rap1 KO cells. Green, telomeric FISH; blue, DNA (DAPI).
(E) Quantification of telomere fusions, detected as in (D), in the indicated clones. p values from a two-tailed paired t test on combined WT and KO data sets.
(F) CO-FISH analysis on the indicated WT and KO HeLa clones.
(G) Table showing the percentage of telomeres showing T-SCEs as assayed in (F) in the indicated clones. p value from unpaired two-tailed t test.
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Figure 3. Loss of Rap1 Does Not Affect Telomere Structure
(A) Southern blot of telomeric restriction fragments from two WT and two KO
HT1080 clones at the indicated PDs.
(B–D) Curves of average telomere lengths at indicated PDs in HT1080,
HCT116, and ARPE-19 clones, respectively.
See also Figure S2.that recombination remained repressed at telomeres (Figures 2F
and 2G). Thus, human telomeres remain protected from NHEJ
and HDR in the absence of Rap1.
Unaltered Telomere Length Dynamics in the Absence
of Rap1
To determine whether Rap1 affected telomere length homeosta-
sis, two HT1080 Rap1-deficient clones were cultured for 50 pop-
ulation doublings (PD) alongside two Rap1-proficient clones
selected for theirmatching telomere lengths (Figure3A).All clones
exhibited a mild increase in telomere length (Figure 3B). The two
Rap1-deficient clones lengthened their telomeres at a similarCell Remodest rate (1–2bp/PD),whereas the twoRap1-proficient clones
differed in the rate of telomere lengthening (28 and 4 bp/PD) (Fig-
ure 3B). Given the clonal variation and small differences in telo-
mere length changes, the removal of Rap1 did not appear to
have a strong effect on telomere length dynamics inHT1080cells.
Similarly, Rap1 did not affect the telomere length dynamics of
HCT116 clones (Figure 3C). Two Rap1-deficient clones showed
telomere shortening at variable rates (3 to 32 bp/PD). Given
that the telomere shortening in the parental cells (27 bp/PD)
is similar to that of one of the Rap1-deficient clones (c10), we
conclude that also in HCT116 cells, Rap1 did not strongly affect
telomere dynamics.
Finally, three Rap1-deficient ARPE-19 clones (c26, c25, and
c30) showed wide variations in telomere dynamics, ranging
from slight shortening (18 bp/PD) to slight elongation (9 and
16 bp/PD) (Figure 3D). The single Rap1-proficient clone (c23)
showed telomere shortening at a rate of 34 bp/PD. Thus, there
is considerable variability in the telomere dynamics in ARPE-19
clones but no consistent effect of Rap1 deletion.
Given the lack of consistent shortening or lengthening pheno-
types in multiple Rap1 KOs, the simplest interpretation is that
Rap1 does not play a major role in telomere length regulation.
Deletion of Rap1 also did not induce an obvious change in the
telomere length heterogeneity (Figures 3A and S2A), which
was affected by Rap1 mutants in overexpression studies (Li
and de Lange, 2003).
No Change in the Telomeric Overhang after Rap1 Loss
Removal of Rap1 from several cell lines also did not appear to
affect the 30 telomeric overhang. The amount of ss telomeric
DNA was determined by in-gel hybridization of a labeled
C-strand telomeric repeat probe to native telomeric restriction
fragments. Quantification of normalized ss telomeric DNA sig-
nals indicated that Rap1 status had no significant impact on
the 30 overhangs in HT1080, HCT116, and ARPE-19 cells (Fig-
ures S2A and S2B).
Unaltered Telomeric Positioning
To determine whether Rap1 is involved in the peripheral posi-
tioning of telomeres in newly formed G1 cells (Crabbe et al.,
2012), we used mitotic shake-off and analyzed daughter cells
in early G1. Using lamin A to mark the nuclear envelope (NE)
and FISH to visualize telomeres, the subnuclear position of the
telomeric signals was determined and compared between
Rap1-proficient and Rap1-deficient cells (Figures 4A and 4B).
The distribution of telomeres in the nucleus andmedian distance
from the nuclear envelope was similar for two Rap1-proficient
and Rap1-deficient clones in two independent experiments.
Moreover, the percentage of telomeres present in a zone defined
arbitrarily as the nuclear periphery (within 10% distance from the
NE) was also similar regardless of Rap1 status, illustrating that
Rap1 is not required for the more peripheral positioning of telo-
meres in early G1.
Rap1 Affects Transcriptional Regulation, Not Telomeric
Chromatin Modification
Mouse Rap1 localizes to over 8,600 gene-associated loci,
affecting transcription of numerous genes (Martinez et al.,ports 9, 1273–1280, November 20, 2014 ª2014 The Authors 1277
Figure 4. Effects of Rap1 on Telomere Posi-
tion, Chromatin Modification, and Gene
Expression
(A) Combined IF for lamin A (red) and FISH for
telomeres (green) in early G1 nuclei of WT and
Rap1 KO HeLa1.3 clones. The scale in one nu-
cleus indicates how the position of the telomeric
signals was determined. Blue: DAPI DNA stain.
(B) Distance of telomeres from nuclear envelope
(NE) in arbitrary units. For each nucleus imaged in
a single plane, the ratio between the distance of
each telomere from the center and the radius
(center to NE) was plotted. Median distance for
each clone is indicated by horizontal line. ‘‘%
telomeres close to NE’’ reflects telomeres within
10% of the distance from the NE. Two indepen-
dent experiments for each clone are shown.
(C) ChIP for modified histones at telomeres in WT
and Rap1 KO cells. Duplicate blots were probed
for telomeric DNA or Alu repeats.
(D) Relative telomeric ChIP signals obtained as
in (C) were expressed as the ratio of signal in
KO and WT clones (WT set to 1). Values repre-
sent averages of two experiments. Error bars
represent SEM.
See also Tables S1–S3 and Figure S3.2010; Yeung et al., 2013; Martı´nez et al., 2013), while human
Rap1 is found at 63 gene loci (Yang et al., 2011). To
query the effect of Rap1 on the transcriptome, we performed
microarray profiling on seven Rap1 wild-type (WT) and KO
clones derived from three different cell lines: ARPE-19,
HT1080, and HCT116. A number of differentially regulated
genes were identified (Tables S1–S3). The three Rap1-regu-
lated genes in the ARPE-19 cells (LHX2, LRRC17, and CDO1)
were validated by quantitative RT-PCR (qRT-PCR), and their
response to Rap1 deletion was further confirmed on an addi-
tional ARPE-19 Rap1 KO clone (c26) (Figures S3A–S3C). The
Rap1-regulated genes varied between the different cell lines,
most likely due to the different origins of the cell lines. Gene
ontology analysis was uninformative, because of the low
number of genes identified by this limited analysis. However,
one Rap1-regulated gene in the HT1080 cells was among the
human Rap1-associated loci in the HT1080-derived HTC75
cell line (Yang et al., 2011). Taken together, these data are
consistent with a role for Rap1 in transcriptional control in hu-
man cells.1278 Cell Reports 9, 1273–1280, November 20, 2014 ª2014 The AuthorsDespite the effects of Rap1 on gene
expression there was no significant effect
of Rap1 on the abundance of the telo-
meric long noncoding RNA called TERRA
(telomeric repeat-containing RNA; re-
viewed in Feuerhahn et al., 2010) (Figures
S3D and S3E). This finding is consistent
with the unaltered TERRA levels after
deletion of mouse Rap1 (Sfeir et al.,
2010). Deletion of human Rap1 also had
no detectable effect on general markers
for the chromatin status at telomeres, asevidenced by ChIP for methylation of H3K9, acetylation of H4,
and HP1a, HP1b, and HP1g (Figures 4C and 4D).
DISCUSSION
Based on the genetic data presented here, we conclude that hu-
man Rap1 is not required for the protection of telomeres from
NHEJ and has no obvious effect on telomere length regulation,
contrary to what was anticipated from other studies (Bae and
Baumann, 2007; Sarthy et al., 2009; Li and de Lange, 2003;
O’Connor et al., 2004). In addition, telomeres lacking Rap1 re-
mained protected from DNA damage signaling and HDR and
had a normal 30 overhang. These findings are in agreement
with the mouse Rap1 KO, which revealed no obvious phenotype
other than that of telomeres becoming prone to undergo HDR
when Ku70/80 was absent (Sfeir et al., 2010). Whether human
telomeres lacking Rap1 also recombine more readily in a
Ku70/80-deficient setting is difficult to assess, since deletion of
human Ku70/80 leads to rapid telomere loss and cell death (Li
et al., 2002; Wang et al., 2009).
Despite this lack of requirement for Rap1 at telomeres, the hu-
man gene encoding Rap1 has diverged little from its chimpanzee
counterpart (1 base change/100 codons; 0.25 aa changes/
100 aa), whereas the genes for other shelterin components
show much greater divergence (e.g., 3.6, 2.4, and 1.7 base
changes/100 codons and 2.2, 1.1, and 0.65 aa changes/
100 aa for TRF2, TRF1, and TIN2, respectively). Furthermore,
assessment of a gene damage index for all protein-coding genes
places TERF2IP in the top 20% of human genes with regard to
mutation intolerance (Y. Itan, personal communication). In addi-
tion, Rap1 ranks among the top 10% of human genes in terms of
‘‘functional indispensability,’’ a characteristic that incorporates
gene centrality (based on interaction data pooled from various
biological systems), structural information, and evolutionary
constraints (Khurana et al., 2013). In this regard, only TIN2 scores
higher than Rap1, as expected based on its multiple interaction
interfaces in shelterin.
These results raise the question why Rap1 is conserved. It
appears unlikely that protection of telomeres from HDR is its
sole raison d’e^tre, given the additional repression by Ku70/80.
Furthermore, it seems unlikely that Rap1 has a tissue-specific
role at telomeres, given that mice lacking Rap1 are alive and
largely normal and the lack of telomeric phenotypes upon
Rap1 deletion from four human cell lines of different tissue origin.
The conservation of Rap1 is also not explained by a role in
meiosis, since the Rap1 KO mice are fertile and, unlike yeast
lacking Rap1, form a normal meiotic bouquet (Kanoh and Ishi-
kawa, 2001; Chikashige and Hiraoka, 2001; Chikashige et al.,
2006; Sfeir et al., 2010; Scherthan et al., 2011; Shibuya et al.,
2014). It is not excluded that Rap1, like TIN2, has (as yet un-
known) multiple interactions within shelterin or interacts with
shelterin-associated factors that explain its conservation or
that its role at telomeres is redundant. However, we favor the
idea that the conservation of Rap1 is due to its role in transcrip-
tional regulation, where it may have multiple distinct interaction
partners that constrain its evolution. It will be of interest to iden-
tify the Rap1-interacting partners that are at gene loci, since such
partners may well be used by Rap1 to fulfill (as yet undefined)
telomere functions.
Our data point to the difficulty in interpreting experiments in
which telomeric phenotypes are observed upon overexpression
of shelterin (mutant) proteins or their partial inactivation by
shRNAs. We suspect that the prior finding of changes in telo-
mere length and heterogeneity upon overexpression of Rap1
mutants (Li and de Lange, 2003) were due to nucleoplasmic titra-
tion of factors that (indirectly) influence these phenotypes. Simi-
larly, the artificial tethering of Rap1 to telomeresmay have had an
effect on NHEJ that does not reflect the normal function of the
protein (Sarthy et al., 2009).
These data indicate that while mammalian Rap1 has function-
ally diverged away from its yeast predecessors, mouse and hu-
man Rap1 are very similar. Both Rap1 KO mice and human cells
are viable, lack hallmarks of telomere dysfunction, and have no
overt change in telomere length settings.While the Rap1 compo-
nents of human and mouse shelterin are indistinguishable, it will
be important to query the functions of other shelterin compo-
nents and associated factors to gain a complete understanding
of telomeremaintenance and protection in human cells. Our dataCell Reshow that genetic approaches, such as the use of TALENs and
CRISPR (Hsu et al., 2014), are versatile tools to this effect.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are available in Supplemental Experimental
Procedures. Cell culture techniques, telomere length analysis, telomeric over-
hang assay, analysis of metaphase spreads, TIF analysis, ChIP, telomeric
FISH, immunofluorescence, and immunoblotting analysis were performed as
described previously (Sfeir et al., 2010; Takai et al., 2010). TALENs KO of
TERF2IP was performed using standard protocols (Chen et al., 2011). The
assay for telomeric position was published previously (Crabbe et al., 2012).
Microarray analysis was performed using Whole Human Genome DNA micro-
arrays (Illumina HumanHT-12 v4) with GeneSpring v12.6 for data analysis.
ACCESSION NUMBERS
Microarray data have been deposited in the Gene Expression Omnibus under
the accession number GSE61900.
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Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.10.014.
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